Sentence examples for extra terminal from inspiring English sources

Closed-loop stability is treated by adding extra terminal cost constraints.

Blum, K. A. et al. A phase I study of CPI-0610, a bromodomain and extra terminal protein (BET) inhibitor in patients with relapsed or refractory lymphoma.

Outside the south-east, the CBI said "priority" developments should include a new runway in the Midlands, an extra terminal at Manchester and expansion at Cardiff, Bristol, Newcastle and Liverpool.

Gautam Borthakur, J. E. W. et al. First-in-human study of ABBV-075 (mivebresib), a pan-inhibitor of bromodomain and extra terminal (BET) proteins, in patients (pts) with relapsed/refractory (RR) acute myeloid leukemia (AML): Preliminary data.

The double bromodomain-containing BET (bromodomain and extra terminal) family of proteins is highly conserved from yeast to humans and consists not just of transcriptional regulators but also histone-interacting chromatin remodelers.

Mark Dawson, E. M. S. et al. A phase I study of GSK525762, a selective bromodomain (BRD) and extra terminal protein (BET) inhibitor: results from part 1 of phase I/II open label single agent study in patients with acute myeloid leukemia (AML).

A spokesman for the DWP said that the search for work had become increasingly digital in the last decade and that over the next six months, wifi and 6,000 extra terminals would be installed into jobcentres across the country so jobseekers had access to the latest technology.

The bromodomain and extra-terminal domain (BET) family: functional anatomy of BET paralogous proteins.

These marks are read by bromodomain and extra-terminal (BET) proteins, whose targeted inhibitors are under clinical investigation.

The bromodomain and extra-terminal motif (BET) protein BRD4 binds to acetylated histones at enhancers and promoters via its bromodomains (BDs) to regulate transcriptional elongation.

The bromodomain and extra-terminal proteins (BET) have emerged as promising therapeutic targets for the treatment of castration-resistant prostate cancer (CRPC).